AD-35 / Zhejiang Hisun - LARVOL DELTA

ROAD: Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - P2a; N=55; Active, not recruiting; Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd.; Recruiting ➔ Active, not recruiting; N=88 ➔ 55; Trial completion date: Jul 2020 ➔ Dec 2020; Trial primary completion date: Jul 2019 ➔ Dec 2020

Clinical • Enrollment change • Enrollment closed • Trial completion date • Trial primary completion date